Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Pacira Pharmaceuticals ( (PCRX) ) has provided an announcement.
Pacira BioSciences has appointed Shawn Cross as its new Chief Financial Officer, bringing over 25 years of biopharmaceutical and financial expertise to the company. Previously, Cross held leadership roles at Applied Molecular Transport, including CEO, and has a strong background in investment banking. His appointment is aimed at enhancing Pacira’s financial strategies as the company continues to grow its innovative non-opioid pain therapies. Cross’s role will also include participation in the company’s incentive programs, aligning with its long-term growth objectives.
For detailed information about PCRX stock, go to TipRanks’ Stock Analysis page.
